Royal Bank of Canada’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-200
| Closed | -$1K | – | 8257 |
|
|
2021
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 7577 |
|
|
2021
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 7421 |
|
|
2021
Q1 | $1K | Sell |
200
-42
| -17% | -$219 | ﹤0.01% | 7365 |
|
|
2020
Q4 | $1K | Sell |
242
-169
| -41% | -$723 | ﹤0.01% | 7015 |
|
|
2020
Q3 | $2K | Sell |
411
-1,453
| -78% | -$5.62K | ﹤0.01% | 6366 |
|
|
2020
Q2 | $5K | Buy |
1,864
+1,567
| +528% | +$4.61K | ﹤0.01% | 6072 |
|
|
2020
Q1 | $1K | Sell |
297
-2,498
| -89% | -$11.2K | ﹤0.01% | 6565 |
|
|
2019
Q4 | $11K | Sell |
2,795
-5,204
| -65% | -$24.9K | ﹤0.01% | 6127 |
|
|
2019
Q3 | $41K | Buy |
7,999
+381
| +5% | +$2.35K | ﹤0.01% | 5211 |
|
|
2019
Q2 | $48K | Buy |
7,618
+18
| +0.2% | +$104 | ﹤0.01% | 5299 |
|
|
2019
Q1 | $54K | Hold |
7,600
| – | – | ﹤0.01% | 5122 |
|
|
2018
Q4 | $65K | Buy |
7,600
+4,408
| +138% | +$57.3K | ﹤0.01% | 4963 |
|
|
2018
Q3 | $64K | Buy |
3,192
+471
| +17% | +$11.1K | ﹤0.01% | 5111 |
|
|
2018
Q2 | $71K | Buy |
2,721
+221
| +9% | +$6.12K | ﹤0.01% | 4998 |
|
|
2018
Q1 | $60K | Sell |
2,500
-77
| -3% | -$2.43K | ﹤0.01% | 4974 |
|
|
2017
Q4 | $88K | Sell |
2,577
-1,237
| -32% | -$34.5K | ﹤0.01% | 4890 |
|
|
2017
Q3 | $81K | Sell |
3,814
-6,308
| -62% | -$116K | ﹤0.01% | 5151 |
|
|
2017
Q2 | $177K | Sell |
10,122
-555
| -5% | -$9.18K | ﹤0.01% | 4436 |
|
|
2017
Q1 | $187K | Buy |
10,677
+9,665
| +955% | +$165K | ﹤0.01% | 4371 |
|
|
2016
Q4 | $17K | Buy |
+1,012
| New | +$15.7K | ﹤0.01% | 5864 |
|
|
2016
Q1 | – | Sell |
-13
| Closed | – | – | 6771 |
|
|
2015
Q4 | $0 | Sell |
13
-441
| -97% | -$7.42K | ﹤0.01% | 6918 |
|
|
2015
Q3 | $8K | Sell |
454
-410
| -47% | -$9.33K | ﹤0.01% | 6004 |
|
|
2015
Q2 | $23K | Buy |
+864
| New | +$16.8K | ﹤0.01% | 5632 |
|
|
2015
Q1 | – | Sell |
-13
| Closed | – | – | 6498 |
|
|
2014
Q4 | $0 | Buy |
+13
| New | +$197 | ﹤0.01% | 6360 |
|
Royal Bank of Canada's ADMS Position: Q4 2021 in Review
Royal Bank of Canada sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 200 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in ADMS in Q4 2014 and held it in 24 quarters. The position peaked at $187K in Q1 2017. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.
- Royal Bank of Canada reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Royal Bank of Canada sold 200 Adamas Pharmaceuticals shares in Q4 2021, an estimated $1K.
- Royal Bank of Canada first reported a position in Adamas Pharmaceuticals in Q4 2014 and held it in 24 quarters.
- Royal Bank of Canada's Adamas Pharmaceuticals position peaked at $187K in Q1 2017.
- 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.
Based on Royal Bank of Canada's 13F filing for Q4 2021, filed 14 Feb 2022.